Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis

(2017) Nobuyuki Toshikuni   Gut and Liver

Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis

(2016) Sashidhar Manthravadi et al.   INTERNATIONAL JOURNAL OF CANCER

Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge

(2016) Anne De Monte et al.   JOURNAL OF CLINICAL VIROLOGY

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

(2016) Fabio Conti et al.   JOURNAL OF HEPATOLOGY

Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment

(2016) Harrys A. Torres et al.   JOURNAL OF HEPATOLOGY

Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

(2016) Calogero Cammà et al.   JOURNAL OF HEPATOLOGY

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

(2016) María Reig et al.   JOURNAL OF HEPATOLOGY

Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection

(2016) Masahiro Kobayashi et al.   JOURNAL OF MEDICAL VIROLOGY

Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir: Figure 1.

(2015) Jeffrey M. Collins et al.   CLINICAL INFECTIOUS DISEASES

Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function

(2015) Elisavet Serti et al.   GASTROENTEROLOGY

Effects of antiviral therapy for hepatitis C following treatment of hepatocellular carcinoma: survey findings of the Japanese Red Cross Liver Study Group

(2015) Kouji Joko et al.   HEPATOLOGY RESEARCH

Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection

(2015) Hiroki Takayama et al.   HEPATOLOGY RESEARCH

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

(2014) Eric G. Meissner et al.   JOURNAL OF CLINICAL INVESTIGATION

Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy

(2011) Yuko Nagaoki et al.   JOURNAL OF GASTROENTEROLOGY

Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach

(2010) Ying-Chun Shen et al.   JOURNAL OF HEPATOLOGY

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis

(2009) S. Breitenstein et al.   BRITISH JOURNAL OF SURGERY

Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma

(2009) Y. Miyake et al.   JOURNAL OF VIRAL HEPATITIS

Impact of Interferon Therapy after Curative Treatment of Hepatocellular Carcinoma

(2008) Masatoshi Kudo   ONCOLOGY